Raffles Medical Group Likely Has Ability to Enhance Shareholder Returns -- Market Talk

Dow Jones

Jan 06

0638 GMT - Raffles Medical Group likely has the ability to enhance shareholder returns, CGS International's Tay Wee Kuang says in a research report. Given its net cash position of around S$283 million as of 1H 2025, the healthcare provider could boost shareholder returns via ways such as special dividends, the analyst says. With 2026 as the Singapore-listed company's 50th anniversary, it could augment its core dividend of 2.5 Singapore cents with additional 2.5 Singapore cents to bring 2025's dividend to 5.0 Singapore cents. The brokerage raises the stock's target price to S$1.23 from S$1.20 to reflect a valuation roll-forward, with an unchanged add rating. Shares are unchanged at S$1.01. (ronnie.harui@wsj.com)

(END) Dow Jones Newswires

January 06, 2026 01:38 ET (06:38 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2601869349"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2601869349\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2601869349?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-06 14:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601869349","market":"other","top_or_hot":-1,"title":"Raffles Medical Group Likely Has Ability to Enhance Shareholder Returns -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0638 GMT - Raffles Medical Group likely has the ability to enhance shareholder returns, CGS International's Tay Wee Kuang says in a research report. Given its net cash position of around S$283 million as of 1H 2025, the healthcare provider could boost shareholder returns via ways such as special dividends, the analyst says. With 2026 as the Singapore-listed company's 50th anniversary, it could augment its core dividend of 2.5 Singapore cents with additional 2.5 Singapore cents to bring 2025's dividend to 5.0 Singapore cents. The brokerage raises the stock's target price to S$1.23 from S$1.20 to reflect a valuation roll-forward, with an unchanged add rating. Shares are unchanged at S$1.01. (ronnie.harui@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 06, 2026 01:38 ET (06:38 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Raffles Medical Group Likely Has Ability to Enhance Shareholder Returns -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRaffles Medical Group Likely Has Ability to Enhance Shareholder Returns -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-06 14:38</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0638 GMT - Raffles Medical Group likely has the ability to enhance shareholder returns, CGS International's Tay Wee Kuang says in a research report. Given its net cash position of around S$283 million as of 1H 2025, the healthcare provider could boost shareholder returns via ways such as special dividends, the analyst says. With 2026 as the Singapore-listed company's 50th anniversary, it could augment its core dividend of 2.5 Singapore cents with additional 2.5 Singapore cents to bring 2025's dividend to 5.0 Singapore cents. The brokerage raises the stock's target price to S$1.23 from S$1.20 to reflect a valuation roll-forward, with an unchanged add rating. Shares are unchanged at S$1.01. (ronnie.harui@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 06, 2026 01:38 ET (06:38 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSL.SI","symbol_name":"莱佛士医疗","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2601869349","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601869349","pubTimestamp":1767681480,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0638 GMT - Raffles Medical Group likely has the ability to enhance shareholder returns, CGS International's Tay Wee Kuang says in a research report. Given its net cash position of around S$283 million as of 1H 2025, the healthcare provider could boost shareholder returns via ways such as special dividends, the analyst says. With 2026 as the Singapore-listed company's 50th anniversary, it could augment its core dividend of 2.5 Singapore cents with additional 2.5 Singapore cents to bring 2025's dividend to 5.0 Singapore cents. The brokerage raises the stock's target price to S$1.23 from S$1.20 to reflect a valuation roll-forward, with an unchanged add rating. Shares are unchanged at S$1.01. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BSL.SI":"莱佛士医疗","BK6511":"医疗保健服务概念","ABIL":"Ability Inc","BK6092":"保健护理机构"},"translate_title":"莱佛士医疗集团可能有能力提高股东回报——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSL.SI":1.5,"ABIL":1.5},"content_text":"0638 GMT - Raffles Medical Group likely has the ability to enhance shareholder returns, CGS International's Tay Wee Kuang says in a research report. Given its net cash position of around S$283 million as of 1H 2025, the healthcare provider could boost shareholder returns via ways such as special dividends, the analyst says. With 2026 as the Singapore-listed company's 50th anniversary, it could augment its core dividend of 2.5 Singapore cents with additional 2.5 Singapore cents to bring 2025's dividend to 5.0 Singapore cents. The brokerage raises the stock's target price to S$1.23 from S$1.20 to reflect a valuation roll-forward, with an unchanged add rating. Shares are unchanged at S$1.01. (ronnie.harui@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 06, 2026 01:38 ET (06:38 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}